The shares were sold at an average price of $3.50, for a total value of $105,000.00. The specialty pharmaceutical company reported ($0.03) EPS for the quarter, meeting the Thomson Reuters' consensus estimate of ($0.03). Valley Natl Bancorp now has $2.91B valuation.
On November 8 HC Wainwright held the stock rating at "Buy" targeting a price of $3.50. Wells Fargo Com Mn reported 0% of its portfolio in Antares Pharma Inc (NASDAQ:ATRS).
Thompson Davis & Co increased its stake in Antares Pharma Inc (ATRS) by 181.83% based on its latest 2017Q2 regulatory filing with the SEC. Manufacturers Life Insur The holds 0% of its portfolio in Antares Pharma Inc (NASDAQ:ATRS) for 121,633 shares. The Armistice Capital Llc holds 5.70 million shares with $18.35M value, down from 8.70M last quarter. Natl Bank Of Mellon Corporation has invested 0% in Antares Pharma Inc (NASDAQ:ATRS). Its down 0.80, from 2.87 in 2017Q1. About 1.03 million shares traded.
Nationwide Fund Advisors bought a new position in shares of Antares Pharma, Inc. It has outperformed by 190.44% the S&P500.
Jameis Winston could miss more than two games — Bucs GM
The veteran quarterback will start his second straight game this Sunday against the Dolphins in Miami, the team announced. Winston led the Buccaneers to a disappointing 2-6 record in his eight starts this season.
Investors sentiment increased to 0.94 in Q2 2017. Its up 0.05, from 1.53 in 2017Q1. It fall, as 16 investors sold ATRS shares while 14 reduced holdings. 112 funds opened positions while 620 raised stakes. Vandermosten now forecasts that the specialty pharmaceutical company will earn ($0.12) per share for the year, up from their prior forecast of ($0.14). Geode Mngmt Ltd Liability invested in 0% or 1.19 million shares. Loomis Sayles & Limited Partnership holds 0% or 2,825 shares in its portfolio. Benjamin F Edwards And owns 6,000 shares for 0% of their portfolio. Gru One Trading LP owns 1,800 shares or 0% of their United States portfolio. Lowe Brockenbrough & reported 1.5% of its portfolio in Procter & Gamble Co (NYSE:PG). Parthenon Limited Com invested 3.69% of its portfolio in Procter & Gamble Co (NYSE:PG). Blackrock Incorporated stated it has 9.18M shares. Sfe Inv Counsel reported 60,000 shares stake. Centers Of America Inc accumulated 0.83% or 126,738 shares. Barclays Public Ltd Company has invested 0% in Valley National Bancorp (NYSE:VLY). The Pennsylvania-based Susquehanna Int Gru Llp has invested 0% in Valley National Bancorp (NYSE:VLY).
Since June 9, 2017, it had 1 buying transaction, and 0 insider sales for $363,272 activity. Louvet Patrice sold $2.55 million worth of Procter & Gamble Co (NYSE:PG) on Friday, May 19. The stock has "Strong Buy" rating by Raymond James on Tuesday, January 3. Therefore 46% are positive. The firm has "Outperform" rating by Credit Suisse given on Thursday, February 4. UBS maintained it with "Neutral" rating and $81 target in Monday, October 26 report. The firm earned "Buy" rating on Tuesday, July 25 by Piper Jaffray. The firm has "Hold" rating by SunTrust given on Thursday, October 5. As per Friday, August 26, the company rating was upgraded by Johnson Rice. The stock has "Buy" rating by H.C. Wainwright on Monday, October 23.
Average true range (ATR-14) of the company sets at 0.41, along with its weekly and monthly volatility of 14.66% and 7.35% respectively. Goldman Sachs downgraded the shares of PG in report on Monday, January 9 to "Sell" rating. Armistice Capital Ltd Liability accumulated 5.70M shares.
Armistice Capital Llc, which manages about $784.66M US Long portfolio, upped its stake in Nomad Foods Ltd by 332,000 shares to 1.46 million shares, valued at $20.54M in 2017Q2, according to the filing.
The Savant Capital LLC Lowers Stake in Costco Wholesale Corporation (COST)
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink . COPYRIGHT VIOLATION WARNING: This news story was reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal.
According to 3 analysts Otonomy Inc (NASDAQ:OTIC)'s price will reach at $10.67 during 52 weeks.
More notable recent Antares Pharma Inc (NASDAQ:ATRS) news were published by: Fool.com which released: "Why Antares Pharma Inc Plummeted Today" on October 13, 2017, also Seekingalpha.com with their article: "Antares Pharma: A Company To Keep An Eye On" published on October 18, 2017, Globenewswire.com published: "Antares Pharma to Report Third Quarter 2017 Financial and Operating Results ..." on October 31, 2017. Therefore 43% are positive. Antares Pharma had 10 analyst reports since March 9, 2016 according to SRatingsIntel. Atlantic Tru Limited Liability Co holds 0% of its portfolio in Antares Pharma Inc (NASDAQ:ATRS) for 125,000 shares. Jefferies maintained the shares of ATRS in report on Wednesday, March 9 with "Buy" rating. On Friday, September 8 the stock rating was initiated by H.C. Wainwright with "Buy".
While looking at the Stock's Performance, Antares Pharma Inc. now shows a Weekly Performance of -8.99%, where Monthly Performance is -25.86%, Quarterly performance is -42.86%, 6 Months performance is -36.3% and yearly performance percentage is -8.02%. The stock has "Buy" rating by Piper Jaffray on Tuesday, July 25. The firm has "Buy" rating by Jefferies given on Tuesday, October 10.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.
Hard Facts About Kinross Gold Corporation (NYSE:KGC)
TRADEMARK VIOLATION WARNING: This news story was first posted by Week Herald and is the property of of Week Herald. Vanguard Group Inc. boosted its holdings in shares of Kinross Gold Corporation by 4.6% during the second quarter.